Featured Article

Programming Considerations with the Cochlear™ Nucleus® Hybrid™ Implant System

The Cochlear™ Nucleus® Hybrid™ Implant System is the only FDA-approved electric-plus-acoustic (EAS) system for today’s adults with high-frequency sensorineural hearing loss.

Want to see the latest programming recommendations? Visit myCochlear Clinic today and open the Hybrid Desk Reference Guide in the Hybrid Product Information section to learn more.

HINT: Start with programming the acoustic component first, followed by electrode array programming – be sure to verify/validate with real-ear or an aided soundfield audiogram.

Latest News